Neonatal hyperthyroidism following intrauterine hypothyroidism.

Area of Science:

• Neonatal Endocrinology
• Maternal-Fetal Medicine
• Thyroid Disorders

Background:

• Maternal thyrotoxicosis during pregnancy requires careful management.
• Thyroid dysfunction in mothers can impact fetal and neonatal thyroid status.
• Transplacental passage of maternal thyroid-stimulating immunoglobulins is a known mechanism.

Observation:

• An infant born to a mother treated for thyrotoxicosis initially presented with laboratory findings suggestive of hypothyroidism.
• By the sixth day of life, the infant exhibited clinical and laboratory signs of hyperthyroidism.
• This paradoxical presentation underscores the dynamic nature of neonatal thyroid adaptation.

Findings:

• The infant's initial hypothyroidism was likely a transient effect of maternal antithyroid medication or antibodies.
• The subsequent development of hyperthyroidism suggests the infant's own thyroid gland became stimulated, possibly by persistent maternal antibodies.
• This case illustrates a biphasic thyroid dysfunction in an infant exposed to maternal thyrotoxicosis.

Implications:

• Close monitoring of infants born to mothers with thyrotoxicosis is crucial for early detection of thyroid dysfunction.
• A proposed management plan aims to guide clinicians in handling such complex neonatal cases.
• Understanding these transient thyroid shifts is vital for appropriate therapeutic interventions and long-term infant health.